Kulkarni GS - Search Results

1

Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure.

Juvet T, Mari A, Lajkosz K, Wallis CJ, Kuk C, Erlich A, Krimus L, Fleshner NE, Kulkarni GS, Zlotta AR. Juvet T, et al. Among authors: kulkarni gs. Urol Oncol. 2020 Nov;38(11):850.e9-850.e15. doi: 10.1016/j.urolonc.2020.06.031. Epub 2020 Jul 23. Urol Oncol. 2020. PMID: 32712139

2

Evidence for a biopsy derived grade artifact among larger prostate glands.

Kulkarni GS, Al-Azab R, Lockwood G, Toi A, Evans A, Trachtenberg J, Jewett MA, Finelli A, Fleshner NE. Kulkarni GS, et al. J Urol. 2006 Feb;175(2):505-9. doi: 10.1016/S0022-5347(05)00236-3. J Urol. 2006. PMID: 16406982

3

Should finasteride be used to prevent prostate cancer?

Fleshner N, Kulkarni G. Fleshner N, et al. Curr Treat Options Oncol. 2006 Sep;7(5):346-54. doi: 10.1007/s11864-006-0002-0. Curr Treat Options Oncol. 2006. PMID: 16904051 Review.

4

Prostate volume is strongest predictor of cancer diagnosis at transrectal ultrasound-guided prostate biopsy with prostate-specific antigen values between 2.0 and 9.0 ng/mL.

Al-Azab R, Toi A, Lockwood G, Kulkarni GS, Fleshner N. Al-Azab R, et al. Among authors: kulkarni gs. Urology. 2007 Jan;69(1):103-7. doi: 10.1016/j.urology.2006.09.041. Urology. 2007. PMID: 17270628

5

Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy.

Kulkarni GS, Lockwood G, Evans A, Toi A, Trachtenberg J, Jewett MA, Finelli A, Fleshner NE. Kulkarni GS, et al. Cancer. 2007 Jun 15;109(12):2432-8. doi: 10.1002/cncr.22712. Cancer. 2007. PMID: 17497649 Free article.

6

Optimal management of high-risk T1G3 bladder cancer: a decision analysis.

Kulkarni GS, Finelli A, Fleshner NE, Jewett MA, Lopushinsky SR, Alibhai SM. Kulkarni GS, et al. PLoS Med. 2007 Sep;4(9):e284. doi: 10.1371/journal.pmed.0040284. PLoS Med. 2007. PMID: 17896857 Free PMC article.

7

Extended pattern prostate biopsy does not minimize the volume-grade bias in prostate cancer detection.

Al-Ghamdi AM, Lockwood G, Toi A, Kulkarni GS, Evans A, Finelli A, Zlotta AR, Fleshner N. Al-Ghamdi AM, et al. Among authors: kulkarni gs. J Urol. 2008 Apr;179(4):1332-4. doi: 10.1016/j.juro.2007.11.067. Epub 2008 Mar 4. J Urol. 2008. PMID: 18289588

8

Effect of healthcare provider characteristics on nodal yield at radical cystectomy.

Kulkarni GS, Finelli A, Lockwood G, Saravanan A, Evans A, Jewett MA, Trachtenberg J, Robinette M, Fleshner NE. Kulkarni GS, et al. Urology. 2008 Jul;72(1):128-32. doi: 10.1016/j.urology.2008.03.005. Epub 2008 May 2. Urology. 2008. PMID: 18455773

9

Varied definitions of hospital volume did not alter the conclusions of volume-outcome analyses.

Kulkarni GS, Laupacis A, Urbach DR, Fleshner NE, Austin PC. Kulkarni GS, et al. J Clin Epidemiol. 2009 Apr;62(4):400-7. doi: 10.1016/j.jclinepi.2008.07.008. Epub 2008 Nov 14. J Clin Epidemiol. 2009. PMID: 19013765

10

Longer wait times increase overall mortality in patients with bladder cancer.

Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A. Kulkarni GS, et al. J Urol. 2009 Oct;182(4):1318-24. doi: 10.1016/j.juro.2009.06.041. Epub 2009 Aug 14. J Urol. 2009. PMID: 19683272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

281 results

Search Page

Filters